Higher triglyceride serum level increases atherosclerotic index in subjects 50-70 years of age

Main Article Content

Martiem Mawi
Fransisca Chondro
Juni Chudri


Atherosclerosis, the underlying cause of heart attack, stroke and peripheral disease, is a main cause of morbidity and mortality worldwide. Hypercholesterolemia and hypertriglyceridemia are independent factors in the development and progression of atherosclerosis. The atherosclerotic index (AI) is a strong indicator of cardiovascular heart disease. The objective of this study was to determine the relationship between lipid serum level and AI in subjects 50-70 years of age.

A study of cross-sectional design was conducted among male and female subjects 50-70 years of age. The inclusion criteria were: healthy, and capable of active communication. The exclusion criteria were: subjects not completing the study, currently consuming antihyperlipidemic drugs. Lipid profile comprising total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides, and malondialdehyde (MDA), was analyzed using commercial kits. Systolic and diastolic blood pressure and body mass index was measured in all subjects. Atherogenic index was calculated from (total cholesterol – HDL cholesterol) / HDL cholesterol. Multiple linear regression was used to analyze the data.

Mean age of the subjects was 60.6 ± 3.30 years and there was a significant relationship of LDL cholesterol and triglycerides with AI (b=0.009; p=0.000 and b=0.008; p=0.000, respectively). Triglyceride level was the most influencing factor for AI (b=0.008; Beta=0.616; p=0.000)

Higher triglyceride levels increase AI in subjects 50-70 years of age. Subjects with high serum triglyceride level but without symptoms of cardiovascular disease should be examined for the development of coronary artery blockage.

Article Details

How to Cite
Mawi, M., Chondro, F., & Chudri, J. (2015). Higher triglyceride serum level increases atherosclerotic index in subjects 50-70 years of age. Universa Medicina, 34(3), 205–212. https://doi.org/10.18051/UnivMed.2015.v34.205-212
Review Article


Yang RL, Shi YH, Hao G, et al. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr 2008;43:154-8.

Prakash VB, Rao V. A study of body mass index, lipid profile, and free radical status in coronary artery disease. Int J Technic Res Applic 2015;3:26-8.

Lafta MA. A comparative study for some atherogenic indices in sera of myocardial infarction, ischemic heart disease patients and control. J Natural Sci Res 2014:121-8

Gomez M, Vila J, Elosua R, et al. Relationship lipid oxidation with subclinical atherosclerosis and 10-year coronary events in general population. Atherosclerosis 2014;232:134-40.

Vogiatzi G, Tousoulis D, Stefanadis C. The role of oxidative stress in atherosclerosis. Hellenic J Cardiol 2009;50:402-9.

Kaur J, Arora S, Singh B, et al. Role of oxidative stress in pathophysiology of transient ischemic attack and stroke. Int J Biol Med Res 2011:611-15.

Mirghani Z, Zein T. Total and LDL cholesterol as risk factors of ischemic stroke in Emirate patients. Inter J Neurol 2010;1:1-5.

Huerta JM, Gonzalez S, Fernandez S, et al. Lipid peroxidation, antioxidant status and survival in institutionalised elderly: a five-year longitudinal study. Free Rad Res 2006;2:571-78.

Khatib FK, Samadi N, Ghojazade M, et al. Association between inflamatory factor , lipid peroxidation and total antioxidant in non diabetic patients of coronary artery disease. J.Anal Res Clin Med 2014;2:30-5.

Nwagha UI, Ikekpeazu EJ, Ejezie FE, et al. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal woman in Enugu, Nigeria. African Health Sci 2010;3:248-52.

Bharadway R, Mathur K, Sharma D, et al. The relationship between oxidative stress and atherogenic index (AI) in pre eclampsia Sch J App Med Sci 2014;2:3092-6.

Zhou BF. Cooperative meta-analysis group of the working group on obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinesse adults: study on optimal cut off point body mass index and waist circumference in Chinesse adults. Biomed Environ Sci 2002;15:83-96.

Morselhy HF, Reid RG, Yousef S, et al. A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. J Lipid Res 2013;54: 852-8

Jasim RH. Serum malondialdehyde and lipid profile levels of young patients “haven’t a family history of hypertension”: a new study for cases in the civic society. J Chem 2011;1:120-5.

Amirkhizi F, Siassi F, Djalali M, et al. Assessment of oxidative stress marker related to atherosclerosis in pre-hypertensive women. J Teh Univ Heart Circ 2007;15;137-43.

Linna M, Ahotupa M, Lopponen MK, et al. Circulating oxidized LDL lipids when propotined to HDL-C, emerged as a risk factor of all-cause mortality in a population-based survival study. Age Ageing 2013;42:110-3.

Emokpae MA, Uadia PO. Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy. Anemia 2012. Article ID 767501, 5 pages. doi: 10.1155/2012/767501.

Goyal R, Sarwate. A correlative study of hypertension with lipid profile. Impact J 2014;2: 143-50.

Sies H. Total antioxidant capacity: appraisal of concept. J Nutr 2007;137:1493-5.

Koenig W, Karakas M, Zievir A. Oxidized LDL and the risk of coronary heart disease: result from the Monica/Kora Augsburg study. Clin Chem 2011;57:1196-200.

Stocker R, Keaney JF. New insights on oxidative stress in the artery wall. J Tromb Haemost 2005; 3:1825-34.

Ranjit PM, Guntuku GS, Pothineni RB. New atherogenic indices: assessment of cardiovascular risk in postmenopausal dislipidemia. Asian J Medic Sci 2015;6:25-32.

Carmena R, Duriez P, Fruchart JP. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109 (23 Suppl 1):III2-7.